Sequential combination of sonic hedgehog inhibitors followed by consolidation radiotherapy in locally advanced basal cell carcinoma
Clinical and Experimental Dermatology · 2024
DOI: 10.1093/ced/llae068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Experimental Dermatology, 2024. Verfasst von Marie Boileau und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, CHU Lille, Lille, France. Hauptthemen laut MEDLINE: Basal Cell Carcinoma, Skin Neoplasms, Hedgehog Proteins. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Abstract (Originalsprache)
Background
Sonic hedgehog inhibitors (SHHis) are an effective treatment in locally advanced basal cell carcinoma (laBCC). However, the use of these drugs is limited by adverse events, and relapse at discontinuation in around one-half of patients. A few cases of patients treated concomitantly by radiotherapy (RT) and SHHis have been reported in the literature, suggesting that the combination results in an improved overall response. Maintaining complete response after stopping treatment is a concern, especially as resuming treatment in the case of relapse does not guarantee a new therapeutic response. The optimal combination and sequence of treatment to improve local control of laBCCs are not yet defined.
Objectives
We hypothesized that consolidation RT after complete response to SHHis could reduce the risk of relapse at discontinuation.
Methods
We present a case series of patients with laBCCs who achieved complete response after SHHi treatment and were treated with consolidation RT. Patients were evaluated by a skin cancer board. The closure RT technique and dosage were refined by a radiotherapist.
Results
Eleven patients were included. SHHis were prescribed for a median 5 months (range 4–11). Consolidation RT was performed after complete response to SHHis and discontinuation. RT was delivered at a median dose of 45 Gy (range 40.5–66) in 10 fractions (range 9–33). With a median follow-up of 23 months, all patients maintained complete clinical response. This strategy was well tolerated with no grade 3 adverse events.
Conclusions
SHHi treatment followed by consolidation RT after drug discontinuation seems effective and safe. Further studies are needed to develop a precise strategy for the management of laBCCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, CHU Lille, Lille, France.
- Department of Medicine, University of Lille, Lille, France.
- University of Lille, Inserm, CHU Lille, U1189 - ONCO-THAI - Assisted Laser Therapy and Immunotherapy for Oncology, F-Lille, France.
- Medical Office, Medipole Garonne, Toulouse, France.
- CARADERM Network, University Hospital Lille, Lille, France.
- University Department of Radiation Oncology, Oscar Lambret Comprehensive Cancer Center, Lille, France.
ORCID-Profile: Marie Boileau, Manon Dubois, Clément Pruvot, Xavier Mirabel, Laurent Mortier
Zitieren
APA
Boileau, M., Dubois, M., Pruvot, C., Desmedt, E., Templier, C., Meyer, N., Mirabel, X., & Mortier, L. (2024). Sequential combination of sonic hedgehog inhibitors followed by consolidation radiotherapy in locally advanced basal cell carcinoma. Clinical and Experimental Dermatology. https://doi.org/10.1093/ced/llae068
Vancouver
Boileau M, Dubois M, Pruvot C, Desmedt E, Templier C, Meyer N, et al. Sequential combination of sonic hedgehog inhibitors followed by consolidation radiotherapy in locally advanced basal cell carcinoma. Clinical and Experimental Dermatology. 2024. doi:10.1093/ced/llae068
BibTeX
@article{Boileau2024,
author = {Boileau, Marie and Dubois, Manon and Pruvot, Clément and Desmedt, Eve and Templier, Carole and Meyer, Nicolas and Mirabel, Xavier and Mortier, Laurent},
title = {Sequential combination of sonic hedgehog inhibitors followed by consolidation radiotherapy in locally advanced basal cell carcinoma},
journal = {Clinical and Experimental Dermatology},
year = {2024},
doi = {10.1093/ced/llae068}
}
EUVIMED